Adma Biologics (ADMA) Current Taxes (2024 - 2025)
Adma Biologics (ADMA) reported Current Taxes of $8.6 million for Q4 2025, up 147.52% on a YoY basis from $3.5 million in Q4 2024, and up 209.04% quarter-over-quarter from $2.8 million in Q3 2025.
Adma Biologics (ADMA) Current Taxes (2024 - 2025) Analysis & Trends
Adma Biologics has reported Current Taxes for 2 years, with the latest figure at $8.6 million in Q4 2025.
- For the quarter ending Q4 2025, Current Taxes rose 147.52% year-over-year to $8.6 million; the trailing twelve-month figure through Dec 2025 stood at $8.6 million (up 147.52% YoY), and the FY2025 full-year result was $8.6 million, up 147.52% from the prior year.
- Current Taxes for Q4 2025 stood at $8.6 million, up from $2.8 million in the prior quarter.
- The five-year high for Current Taxes was $8.6 million in Q4 2025, with the low at $2.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 8.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Jun 30, 2024 | 2.83 Mn |